0%
Loading ...

N Team

From Vaccines to Targeted Therapy: The Future of Cancer Care

Dr. Christina Annunziata of the American Cancer Society breaks down the latest cancer advances: new multi-cancer blood tests that can detect cancers earlier (including types we currently can’t screen for), why these tests are complementary to — not replacements for — standard screening, and how targeted therapies (like treatments for RET-mutated lung cancer) are extending

From Vaccines to Targeted Therapy: The Future of Cancer Care Read More »

Cathie Wood buys $529.7 million of popular new stock

Cathie Wood, head of Ark Investment Management, has a history of buying stocks shortly after their IPOs.  In recent years, Wood’s Ark funds have invested in newly public companies such as Tempus AI (TEM), Coinbase (COIN), and CoreWeave (CRWV), reflecting her strategy of gaining early exposure to high-growth businesses in artificial intelligence, cryptocurrency, and cloud

Cathie Wood buys $529.7 million of popular new stock Read More »

Schwab reveals surprising shift in AI fraud tactics

A few years ago, you could spot most financial scams by their broken grammar, misspelled logos, or generic language that felt nothing like legitimate correspondence. Charles Schwab’s financial crimes team says those distinctive signs have largely vanished, replaced by attacks driven by artificial intelligence and built around actual personal data. The brokerage published an article

Schwab reveals surprising shift in AI fraud tactics Read More »

SpaceX IPO reminds investors where real fortunes start

The first mistake investors can make with SpaceX is thinking the payday happened all at once. It didn’t. SpaceX’s initial public offering gave retail investors a rare chance to invest in Elon Musk’s rocket, satellite and artificial intelligence enterprise. But for the company’s first believers, the IPO didn’t mark the beginning. It was the end

SpaceX IPO reminds investors where real fortunes start Read More »